DOCSLIB.ORG

A00–B99 Certain Infectious and Parasitic Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A00–B99 Certain Infectious and Parasitic Diseases 1 . Kode Gol. Jenis Penyakit No Title Of Diseases Penyakit Penyakit akibat infeksi & I A00–B99 Certain infectious and parasitic diseases Parasit Neoplasms Keganasan / kanker/tumor II C00–D48 Diseases of the blood and blood-forming Penyakit darah /kelainan III D50–D89 organs and certain disorders involving the darah /keganasan sistem immune mechanism imun Penyakit endokrin & IV E00–E90 Endocrine, nutritional and metabolic diseases metabolik & nutrisi Mental and behavioural disorders Gangguan prilaku & mental V F00–F99 Diseases of the nervous system Penyakit sistem saraf VI G00–G99 Diseases of the eye and anexa Penyakit mata & adnexa VII H00–H59 VIII H60–H95 Diseases of the ear and mastoid process Penyakit telinga & mastoid Penyakit sistem sirkulasi IX I00–I99 Diseases of the circulatory system darah Diseases of the respiratory system Penyakit sistem pernafasan X J00–J99 XI K00–K93 Diseases of the digestive system Penyakit sistem pencernaan Penyakit kulit & jaringan XII L00–L99 Diseases of the skin and subcutaneous tissue subkutan Diseases of the musculoskeletal system and Penyakit sistem otot/rangka XIII M00–M99 connective tissue & jaringan penyambung Penyakit sistem kemih & XIV N00–N99 Diseases of the genitourinary system kelamin Kehamilan, Persalinan & O00–O99 Pregnancy, childbirth and the puerperium XV nifas Certain conditions originating in the perinatal Periode perinatal XVI P00–P96 period Congenital malformations, deformations and Malformasi kongenital, XVII Q00–Q99 chromosomal abnormalities deformitas & abnormal Symptoms, signs and abnormal clinical and Gejala, tanda & abnormas XVIII R00–R99 laboratory findings, not elsewhere classified klinis & temuan lab Cedera, kekerasan dan Injury, poisoning and certain other XIX S00–T98 keadaan lain disebabkan consequences of external causes dari luar Penyebab luar dari XX V01–Y98 External causes of morbidity and mortality kesakitan dan kematian Factors influencing health status and contact XXI Z00–Z99 with health services XXII U00–U99 Codes for special purposes 2 A00–B99 Certain infectious and parasitic diseases (Penyakit akibat infeksi & Parasit) 1 A00–A79 – Bacterial infections, and other intestinal infectious diseases, and STDs o 1.1 (A00–A09) Intestinal infectious diseases o 1.2 (A15–A19) Tuberculosis o 1.3 (A20–A28) Certain zoonotic bacterial diseases o 1.4 (A30–A49) Other bacterial diseases o 1.5 (A50–A64) Infections with a predominantly sexual mode of transmission o 1.6 (A65–A69) Other spirochaetal diseases o 1.7 (A70–A74) Other diseases caused by chlamydiae o 1.8 (A75–A79) Rickettsioses 2 A80–B34 – Viral infections o 2.1 (A80–A89) Viral infections of the central nervous system o 2.2 (A90–A99) Arthropod-borne viral fevers and viral haemorrhagic fevers o 2.3 (B00–B09) Viral infections characterized by skin and mucous membrane lesions o 2.4 (B15–B19) Viral hepatitis o 2.5 (B20–B24) Human immunodeficiency virus (HIV) disease o 2.6 (B25–B34) Other viral diseases 3 B35–B89 – Infections caused by fungi, protozoans, worms, and infestations o 3.1 (B35–B49) Mycoses o 3.2 (B50–B64) Protozoal diseases o 3.3 (B65–B83) Helminthiases o 3.4 (B85–B89) Pediculosis, acariasis and other infestations 4 B90–B99 – Sequelae, and diseases classified elsewhere o 4.1 (B90–B94) Sequelae of infectious and parasitic diseases o 4.2 (B95–B97) Bacterial, viral and other infectious agents o 4.3 (B99) Other infectious diseases 3 5 See also 6 References A00–B99 Certain infectious and parasitic diseases (Penyakit akibat infeksi & Parasit) 1. A00–A79 – Bacterial infections, and other intestinal infectious diseases, and STDs (A00–A09) Intestinal infectious diseases ( A 00) Cholera ( A 01) Typhoid and paratyphoid fevers o ( A 01.0) Typhoid fever . Infection due to Salmonella typhi o ( A 01.1) Paratyphoid fever A o ( A 01.2) Paratyphoid fever B o ( A 01.3) Paratyphoid fever C o ( A 01.4) Paratyphoid fever, unspecified ( A 02) Other Salmonella infections 4 ( A 03) Shigellosis o ( A 03.0) Shigellosis due to Shigella dysenteriae o ( A 03.1) Shigellosis due to Shigella flexneri o ( A 03.2) Shigellosis due to Shigella boydii o ( A 03.3) Shigellosis due to Shigella sonnei o ( A 03.8) Other shigellosis o ( A 03.9) Shigellosis, unspecified . Bacillary dysentery NOS ( A 04) Other bacterial intestinal infections o ( A 04.0) Enteropathogenic Escherichia coli infection o ( A 04.1) Enterotoxigenic Escherichia coli infection o ( A 04.2) Enteroinvasive Escherichia coli infection o ( A 04.3) Enterohaemorrhagic Escherichia coli infection o ( A 04.4) Other intestinal Escherichia coli infections o ( A 04.5) Campylobacter enteritis o ( A 04.6) Enteritis due to Yersinia enterocolitica o ( A 04.7) Enterocolitis due to Clostridium difficile . Pseudomembranous colitis o ( A 04.8) Other specified bacterial intestinal infections o ( A 04.9) Bacterial intestinal infection, unspecified . Bacterial enteritis NOS ( A 05) Other bacterial foodborne intoxications o ( A 05.0) Foodborne staphylococcal intoxication o ( A 05.1) Botulism o ( A 05.2) Foodborne Clostridium perfringens (Clostridium welchii) intoxication ( A 06) Amoebiasis o ( A 06.0) Acute amoebic dysentery o ( A 06.1) Chronic intestinal amoebiasis o ( A 06.2) Amoebic nondysenteric colitis 5 o ( A 06.3) Amoeboma of intestine o ( A 06.4) Amoebic liver abscess o ( A 06.5) Amoebic lung abscess o ( A 06.6) Amoebic brain abscess o ( A 06.7) Cutaneous amoebiasis o ( A 06.8) Amoebic infection of other sites o ( A 06.9) Amoebiasis, unspecified ( A 07) Other protozoal intestinal disease o ( A 07.0) Balantidiasis o ( A 07.1) Giardiasis (lambliasis) o ( A 07.2) Cryptosporidiosis o ( A 07.3) Isosporiasis o ( A 07.8) Other specified protozoal intestinal diseases . Intestinal trichomoniasis . Sarcocystosis . Sarcosporidiosis o ( A 07.9) Protozoal intestinal disease, unspecified ( A 08) Viral and other specified intestinal infections o ( A 08.0) Rotaviral enteritis ( A 09) Diarrhoea and gastroenteritis of presumed infectious origin (A15–A19) Tuberculosis ( A 15) Respiratory tuberculosis, bacteriologically and histologically confirmed ( A 16) Respiratory tuberculosis, not confirmed bacteriologically or histologically ( A 17) Tuberculosis of nervous system o ( A 17.0) Tuberculous meningitis o ( A 17.1) Meningeal tuberculoma o ( A 17.8) Other tuberculosis of nervous system o ( A 17.9) Tuberculosis of nervous system, unspecified ( A 18) Tuberculosis of other organs 6 o ( A 18.0) Tuberculosis of bones and joints o ( A 18.1) Tuberculosis of genitourinary system o ( A 18.2) Tuberculous peripheral lymphadenopathy o ( A 18.3) Tuberculosis of intestines, peritoneum and mesenteric glands o ( A 18.4) Tuberculosis of skin and subcutaneous tissue . Scrofuloderma o ( A 18.5) Tuberculosis of eye o ( A 18.6) Tuberculosis of ear o ( A 18.7) Tuberculosis of adrenal glands o ( A 18.8) Tuberculosis of other specified organs ( A 19) Miliary tuberculosis (A20–A28) Certain zoonotic bacterial diseases ( A 20) Plague o ( A 20.0) Bubonic plague o ( A 20.1) Cellulocutaneous plague o ( A 20.2) Pneumonic plague o ( A 20.3) Plague meningitis o ( A 20.7) Septicaemic plague o ( A 20.8) Other forms of plague o ( A 20.9) Plague, unspecified ( A 21) Tularaemia ( A 22) Anthrax ( A 23) Brucellosis ( A 24) Glanders and melioidosis o ( A 24.0) Glanders o ( A 24.1) acute and fulminating melioidosis o ( A 24.2) Subacute and chronic melioidosis o ( A 24.3) Other melioidosis o ( A 24.4) 7 . Whitmore's disease ( A 25) Rat-bite fevers o ( A 25.0) Spirillosis o ( A 25.1) Streptobacillosis o ( A 25.9) Rat-bite fever, unspecified ( A 26) Erysipeloid ( A 27) Leptospirosis ( A 28) Other zoonotic bacterial diseases, not elsewhere classified o ( A 28.0) Pasteurellosis o ( A 28.1) Cat-scratch disease (A30–A49) Other bacterial diseases ( A 30) Leprosy (Hansen's disease) ( A 31) Infection due to other mycobacteria o ( A 31.0) Pulmonary mycobacterial infection . Infection due to Mycobacterium avium . Infection due to Mycobacterium intracellulare (Battey bacillus) . Infection due to Mycobacterium kansasii o ( A 31.1) Cutaneous mycobacterial infection . Buruli ulcer . Infection due to Mycobacterium marinum . Infection due to Mycobacterium ulcerans o ( A 31.8) Other mycobacterial infections o ( A 31.9) Mycobacterial infection, unspecified . Atypical mycobacterium infection NOS . Mycobacteriosis NOS ( A 32) Listeriosis ( A 33) Tetanus neonatorum ( A 34) Obstetrical tetanus 8 ( A 35) Other tetanus ( A 36) Diphtheria ( A 37) Whooping cough ( A 38) Scarlet fever ( A 39) Meningococcal infection o ( A 39.0) Meningococcal meningitis o ( A 39.1) Waterhouse-Friderichsen syndrome o ( A 39.2) Acute meningococcaemia o ( A 39.3) Chronic meningococcaemia o ( A 39.4) Meningococcaemia, unspecified o ( A 39.5) Meningococcal heart disease ( A 40) Streptococcal septicaemia ( A 41) Other septicaemia o ( A 41.0) Septicaemia due to Staphylococcus aureus o ( A 41.1) Septicaemia due to other specified staphylococcus o ( A 41.2) Septicaemia due to unspecified staphylococcus o ( A 41.3) Septicaemia due to Haemophilus influenzae o ( A 41.4) Septicaemia due to anaerobes o ( A 41.5) Septicaemia due to other Gram-negative organisms o ( A 41.8) Other specified septicaemia o ( A 41.9) Septicaemia, unspecified . Septic shock ( A 42) Actinomycosis ( A 43) Nocardiosis ( A 44) Bartonellosis o ( A 44.0) Systemic bartonellosis o ( A 44.1) Cutaneous and mucocutaneous bartonellosis o ( A 44.8) Other forms of bartonellosis o ( A 44.9) Bartonellosis, unspecified 9 ( A 46) Erysipelas ( A 48) Other bacterial diseases, not elsewhere classified o ( A 48.0) Gas gangrene o ( A 48.1) Legionnaires' disease o ( A 48.2) Nonpneumonic Legionnaires' disease o ( A 48.3) Toxic shock syndrome o ( A 48.4) Brazilian purpuric fever o ( A 48.8) Other specified bacterial diseases ( A 49) Bacterial infection of unspecified site o ( A 49.0) Staphylococcal infection, unspecified o ( A 49.1) Streptococcal infection, unspecified o ( A 49.2) Haemophilus influenzae infection, unspecified o ( A 49.3) Mycoplasma infection, unspecified o ( A 49.8) Other bacterial infections of unspecified site o ( A 49.9) Bacterial infection, unspecified .
Load more

Recommended publications
  • Supernumerary Teeth
    Volume 22, Number 1, 2009 ISSN 1096-9411 Dental Anthropology A Publication of the Dental Anthropology Association Dental Anthropology Volume 22, Number 1, 2009 Dental Anthropology is the Official Publication of the Dental Anthropology Association. Editor: Edward F. Harris Editorial Board Kurt W. Alt (2004-2009) Richard T. Koritzer (2004-2009) A. M. Haeussler (2004-2009) Helen Liversidge (2004-2009) Tseunehiko Hanihara (2004-2009) Yuji Mizoguchi (2006-2010) Kenneth A. R. Kennedy (2006-2010) Lindsay C. Richards (2006-2010) Jules A. Kieser (2004-2009) Phillip W. Walker (2006-2010) Officers of the Dental Anthropology Association Brian E. Hemphill (California State University, Bakersfield) President (2008-2010) G. Richard Scott (University of Nevada, Reno) President-Elect (2008-2010) Loren R. Lease (Youngstown State University, Ohio) Secretary-Treasurer (2007-2009) Simon W. Hillson (University College London) Past-President (2006-2008) Address for Manuscripts Dr. Edward F. Harris College of Dentistry, University of Tennessee 870 Union Avenue, Memphis, TN 38163 U.S.A. E-mail address: [email protected] Address for Book Reviews Dr. Greg C. Nelson Department of Anthropology, University of Oregon Condon Hall, Eugene, Oregon 97403 U.S.A. E-mail address: [email protected] Published at Craniofacial Biology Laboratory, Department of Orthodontics College of Dentistry, The Health Science Center University of Tennessee, Memphis, TN 38163 U.S.A. The University of Tennessee is an EEO/AA/Title IX/Section 504/ADA employer 1 Strong genetic influence on hypocone expression of permanent maxillary molars in South Australian twins Denice Higgins*, Toby E. Hughes, Helen James, Grant C. Townsend Craniofacial Biology Research Group, School of Dentistry, The University of Adelaide, South Australia 5005 ABSTRACT An understanding of the role of genetic be larger in males although this was not statistically influences on dental traits is important in the areas of significant.
    [Show full text]
  • Neonatal Orthopaedics
    NEONATAL ORTHOPAEDICS NEONATAL ORTHOPAEDICS Second Edition N De Mazumder MBBS MS Ex-Professor and Head Department of Orthopaedics Ramakrishna Mission Seva Pratishthan Vivekananda Institute of Medical Sciences Kolkata, West Bengal, India Visiting Surgeon Department of Orthopaedics Chittaranjan Sishu Sadan Kolkata, West Bengal, India Ex-President West Bengal Orthopaedic Association (A Chapter of Indian Orthopaedic Association) Kolkata, West Bengal, India Consultant Orthopaedic Surgeon Park Children’s Centre Kolkata, West Bengal, India Foreword AK Das ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama (021)66485438 66485457 www.ketabpezeshki.com ® Jaypee Brothers Medical Publishers (P) Ltd. Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. Jaypee Brothers Medical Publishers Ltd. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton The Bourse SW1H 0HW (UK) Panama City, Panama 111, South Independence Mall East Phone: +44-2031708910 Phone: +507-301-0496 Suite 835, Philadelphia, PA 19106, USA Fax: +02-03-0086180 Fax: +507-301-0499 Phone: +267-519-9789 Email: [email protected] Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd. Jaypee Brothers Medical Publishers (P) Ltd. 17/1-B, Babar Road, Block-B, Shaymali Shorakhute, Kathmandu Mohammadpur, Dhaka-1207 Nepal Bangladesh Phone: +00977-9841528578 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher.
    [Show full text]
  • Differential Diagnosis of Oromandibular Limb Hypogenesis Syndromes Ole Junga,B, Ralf Smeetsb, Henning Hankenb, Reinhard E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun; 160(2):310-315. A patient with Charlie M Syndrome: Differential diagnosis of Oromandibular Limb Hypogenesis Syndromes Ole Junga,b, Ralf Smeetsb, Henning Hankenb, Reinhard E. Friedrichb, Max Heilandb, Amir Tagnihaa, Brian Labowa Aim. In order to provide adequate treatment to a patient with a subtype of Oromandibular Limb Hypogenesis Syndromes (OLHS), this study aimed to review and to analyze the current literature and treatment options of OLHS. Methods. Literature review in PubMed and Sciencedirect. Due to the small number of results, all available references were analyzed precisely. Results. Cases of OLHS are formerly rare and often incomplete. There are various classifications available, which, however, often seem confusing and are of little practical relevance. Furthermore, we present a complete case report of a patient with Charlie M syndrome, a type IV (Chicarilli)/ V (Hall) OLHS malformation. We also describe embryologic pathogenesis and differential diagnoses. Conclusion. As a result of our literature review, we recommend an adjusted classification for OLHS. Key words: Oromandibular Limb Hypogenesis Syndromes (OLHS), Charlie M Syndrome, Oromandibular and limb hypogenesis malformations (OLHM) Received: August 1, 2015; Accepted with revision: April 8, 2016; Available online: April 27, 2016 http://dx.doi.org/10.5507/bp.2016.020 aDepartment of Plastic and Oral Surgery, Children´s Hospital Boston, Harvard Medical School, Boston, USA bDepartment of Oral and Maxillofacial Surgery, University Medical Center Hamburg, Hamburg, Germany Corresponding author: Ole Jung, e-mail: [email protected] INTRODUCTION CASE REPORT Oromandibular Limb Hypogenesis Syndromes A twenty-three-year-old male with severe oroman- (OLHS) describe a group of heterogeneous malforma- dibular and limb deformities presented for mandibular tions of the face and body.
    [Show full text]
  • Circle Applicable Codes
    IDENTIFYING INFORMATION (please print legibly) Individual’s Name: DOB: Last 4 Digits of Social Security #: CIRCLE APPLICABLE CODES ICD-10 ICD-10 ICD-9 DIAGNOSTIC ICD-9 DIAGNOSTIC PRIMARY ICD-9 CODES CODE CODE PRIMARY ICD-9 CODES CODE CODE Abetalipoproteinemia 272.5 E78.6 Hallervorden-Spatz Syndrome 333.0 G23.0 Acrocephalosyndactyly (Apert’s Syndrome) 755.55 Q87.0 Head Injury, unspecified – Age of onset: 959.01 S09.90XA Adrenaleukodystrophy 277.86 E71.529 Hemiplegia, unspecified 342.9 G81.90 Arginase Deficiency 270.6 E72.21 Holoprosencephaly 742.2 Q04.2 Agenesis of the Corpus Callosum 742.2 Q04.3 Homocystinuria 270.4 E72.11 Agenesis of Septum Pellucidum 742.2 Q04.3 Huntington’s Chorea 333.4 G10 Argyria/Pachygyria/Microgyria 742.2 Q04.3 Hurler’s Syndrome 277.5 E76.01 or 758.33 Aicardi Syndrome 333 G23.8 Hyperammonemia Syndrome 270.6 E72.4 Alcohol Embryo and Fetopathy 760.71 F84.5 I-Cell Disease 272.2 E77.0 Anencephaly 655.0 Q00.0 Idiopathic Torsion Dystonia 333.6 G24.1 Angelman Syndrome 759.89 Q93.5 Incontinentia Pigmenti 757.33 Q82.3 Asperger Syndrome 299.8 F84.5 Infantile Cerebral Palsy, unspecified 343.9 G80.9 Ataxia-Telangiectasia 334.8 G11.3 Intractable Seizure Disorder 345.1 G40.309 Autistic Disorder (Childhood Autism, Infantile 299.0 F84.0 Klinefelter’s Syndrome 758.7 Q98.4 Psychosis, Kanner’s Syndrome) Biotinidase Deficiency 277.6 D84.1 Krabbe Disease 333.0 E75.23 Canavan Disease 330.0 E75.29 Kugelberg-Welander Disease 335.11 G12.1 Carpenter Syndrome 759.89 Q87.0 Larsen’s Syndrome 755.8 Q74.8 Cerebral Palsy, unspecified 343.69 G80.9
    [Show full text]
  • Research Article
    z Available online at http://www.journalcra.com INTERNATIONAL JOURNAL OF CURRENT RESEARCH International Journal of Current Research Vol. 10, Issue, 07, pp.71222-71228, July, 2018 ISSN: 0975-833X RESEARCH ARTICLE THE TONGUE SPEAKS A LOT OF HEALTH. 1,*Dr. Firdous Shaikh, 2Dr. Sonia Sodhi, 3Dr Zeenat Fatema Farooqui and 4Dr. Lata Kale 1PG Student, Department of Oral Medicine and Radiology, CSMSS Dental College and Hospital, Aurangabad 2Professor, Department of Oral Medicine and Radiology, CSMSS Dental College and Hospital, Aurangabad 3Fatema Farooqui, Chief Medical Officer, Sri Ram Homeopathic Clinic and Research Center, Solapur 4Professor and Head, Department of Oral Medicine and Radiology, CSMSS Dental College and Hospital, Aurangabad ARTICLE INFO ABSTRACT Article History: Multifunctional organ of the human body without a bone yet strong is the tongue. It mainly consists Received 26th April, 2018 of the functional portion of muscle mass, mucosa, fat and the specialized tissue of taste i.e. the Received in revised form papillae. Diseases may either result from internal/ systemic causes of extrinsic causes like trauma, 14th May, 2018 infection, etc. A new method for classification has been proposed in this review for diseases of Accepted 09th June, 2018 tongue. This review mainly focuses on encompassing almost each aspect that the body reflects via its th Published online 30 July, 2018 mirror in mouth, the tongue. Key Words: Tongue, Diseases of Tongue, Discoloration of Tongue, Oral health, Hairy Tongue. Copyright © 2018, Firdous Shaikh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Level Estimates of Maternal Smoking and Nicotine Replacement Therapy During Pregnancy
    Using primary care data to assess population- level estimates of maternal smoking and nicotine replacement therapy during pregnancy Nafeesa Nooruddin Dhalwani BSc MSc Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy November 2014 ABSTRACT Background: Smoking in pregnancy is the most significant preventable cause of poor health outcomes for women and their babies and, therefore, is a major public health concern. In the UK there is a wide range of interventions and support for pregnant women who want to quit. One of these is nicotine replacement therapy (NRT) which has been widely available for retail purchase and prescribing to pregnant women since 2005. However, measures of NRT prescribing in pregnant women are scarce. These measures are vital to assess its usefulness in smoking cessation during pregnancy at a population level. Furthermore, evidence of NRT safety in pregnancy for the mother and child’s health so far is nebulous, with existing studies being small or using retrospectively reported exposures. Aims and Objectives: The main aim of this work was to assess population- level estimates of maternal smoking and NRT prescribing in pregnancy and the safety of NRT for both the mother and the child in the UK. Currently, the only population-level data on UK maternal smoking are from repeated cross-sectional surveys or routinely collected maternity data during pregnancy or at delivery. These obtain information at one point in time, and there are no population-level data on NRT use available. As a novel approach, therefore, this thesis used the routinely collected primary care data that are currently available for approximately 6% of the UK population and provide longitudinal/prospectively recorded information throughout pregnancy.
    [Show full text]
  • MECHANISMS in ENDOCRINOLOGY: Novel Genetic Causes of Short Stature
    J M Wit and others Genetics of short stature 174:4 R145–R173 Review MECHANISMS IN ENDOCRINOLOGY Novel genetic causes of short stature 1 1 2 2 Jan M Wit , Wilma Oostdijk , Monique Losekoot , Hermine A van Duyvenvoorde , Correspondence Claudia A L Ruivenkamp2 and Sarina G Kant2 should be addressed to J M Wit Departments of 1Paediatrics and 2Clinical Genetics, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, Email The Netherlands [email protected] Abstract The fast technological development, particularly single nucleotide polymorphism array, array-comparative genomic hybridization, and whole exome sequencing, has led to the discovery of many novel genetic causes of growth failure. In this review we discuss a selection of these, according to a diagnostic classification centred on the epiphyseal growth plate. We successively discuss disorders in hormone signalling, paracrine factors, matrix molecules, intracellular pathways, and fundamental cellular processes, followed by chromosomal aberrations including copy number variants (CNVs) and imprinting disorders associated with short stature. Many novel causes of GH deficiency (GHD) as part of combined pituitary hormone deficiency have been uncovered. The most frequent genetic causes of isolated GHD are GH1 and GHRHR defects, but several novel causes have recently been found, such as GHSR, RNPC3, and IFT172 mutations. Besides well-defined causes of GH insensitivity (GHR, STAT5B, IGFALS, IGF1 defects), disorders of NFkB signalling, STAT3 and IGF2 have recently been discovered. Heterozygous IGF1R defects are a relatively frequent cause of prenatal and postnatal growth retardation. TRHA mutations cause a syndromic form of short stature with elevated T3/T4 ratio. Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.
    [Show full text]
  • Annex 1: List of Medical Case Rates
    ANNEX 1. LIST OF MEDICAL CASE RATES FIRST CASE RATE ICD CODE DESCRIPTION GROUP Professional Health Care Case Rate Fee Institution Fee P91.3 Neonatal cerebral irritability ABNORMAL SENSORIUM IN THE NEWBORN 12,000 3,600 8,400 P91.4 Neonatal cerebral depression ABNORMAL SENSORIUM IN THE NEWBORN 12,000 3,600 8,400 P91.6 Hypoxic ischemic encephalopathy of newborn ABNORMAL SENSORIUM IN THE NEWBORN 12,000 3,600 8,400 P91.8 Other specified disturbances of cerebral status of newborn ABNORMAL SENSORIUM IN THE NEWBORN 12,000 3,600 8,400 P91.9 Disturbance of cerebral status of newborn, unspecified ABNORMAL SENSORIUM IN THE NEWBORN 12,000 3,600 8,400 Peritonsillar abscess; Abscess of tonsil; Peritonsillar J36 ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 cellulitis; Quinsy Other diseases of larynx; Abscess of larynx; Cellulitis of larynx; Disease NOS of larynx; Necrosis of larynx; J38.7 ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 Pachyderma of larynx; Perichondritis of larynx; Ulcer of larynx Retropharyngeal and parapharyngeal abscess; J39.0 ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 Peripharyngeal abscess Other abscess of pharynx; Cellulitis of pharynx; J39.1 ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 Nasopharyngeal abscess Other diseases of pharynx; Cyst of pharynx or nasopharynx; J39.2 ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 Oedema of pharynx or nasopharynx J85.1 Abscess of lung with pneumonia ABSCESS OF RESPIRATORY TRACT 10,000 3,000 7,000 J85.2 Abscess of lung without pneumonia; Abscess of lung NOS ABSCESS OF RESPIRATORY
    [Show full text]
  • Natural Remedies of Common Human Parasites and Pathogens
    ACTA SCIENTIFIC MICROBIOLOGY (ISSN: 2581-3226) Volume 2 Issue 11 November 2019 Investigation Paper Natural Remedies of Common Human Parasites and Pathogens Omar M Amin* Parasitology Center, Scottsdale, Arizona *Corresponding Author: Omar M Amin, Parasitology Center, Scottsdale, Arizona. Received: July 12, 2019; Published: October 16, 2019 DOI: 10.31080/ASMI.2019.02.0401 • Bleeding. • Appetite changes. • Malabsorption. • Mucus. • Rectal itching. • Gut leakage. • Poor digestion. • Systemic/other symptoms • Fatigue. • Skin rash. • Dry cough. • Brain fog/memory loss. • Lymph blockage. Figure 1 • Allergies. • Nausea. Diagnosis and management of: • Muscle or joint pain. • Parasitic organisms and agents of medical and public • Dermatitis. health importance in fecal, blood, skin, urine specimens. • Headaches. • Toxicities related to Neurocutaneous Syndrome (NCS). • Insomnia. Development of anti-parasitic herbal products (F/C/R) Edu- How we get infected cational services: workshops, seminars, training and publications Drinking water or juice: Giardia, Cryptosporidium. provided. 1. 2. Skin contact with contaminated water: Schistosomi- Consultations and protocols for herbal and allopathic treat- asis, swimmers itch. ments. Research: over 220 publications on parasites from all con- Food (fecal-oral infections): most protozoans, ex., tinents. 3. Blastocysts, Entamoeba spp. and worms: Ascaris. Why test? 4. Arthropods: Lyme disease, plague, typhus, etc. You need to be tested if you have one or more of these symp- 5. Air: Upper respiratory tract infections (viruses, bac- toms: teria), ex GI symptoms 6. Pets: Hydatid., flu, Valleycyst disease,fever, Hanta heart virus. worm, larva mi- grans (dogs), Toxoplasma (cats), Taenia (beef, swine. • Diarrhea/constipation. People (contagious diseases): AIDS, herpes. • Irritable bowel 7. Soil: hook worms, thread worms. • Cramps 8.
    [Show full text]
  • Soonerstart Automatic Qualifying Syndromes and Conditions
    SoonerStart Automatic Qualifying Syndromes and Conditions - Appendix O Abetalipoproteinemia Acanthocytosis (see Abetalipoproteinemia) Accutane, Fetal Effects of (see Fetal Retinoid Syndrome) Acidemia, 2-Oxoglutaric Acidemia, Glutaric I Acidemia, Isovaleric Acidemia, Methylmalonic Acidemia, Propionic Aciduria, 3-Methylglutaconic Type II Aciduria, Argininosuccinic Acoustic-Cervico-Oculo Syndrome (see Cervico-Oculo-Acoustic Syndrome) Acrocephalopolysyndactyly Type II Acrocephalosyndactyly Type I Acrodysostosis Acrofacial Dysostosis, Nager Type Adams-Oliver Syndrome (see Limb and Scalp Defects, Adams-Oliver Type) Adrenoleukodystrophy, Neonatal (see Cerebro-Hepato-Renal Syndrome) Aglossia Congenita (see Hypoglossia-Hypodactylia) Aicardi Syndrome AIDS Infection (see Fetal Acquired Immune Deficiency Syndrome) Alaninuria (see Pyruvate Dehydrogenase Deficiency) Albers-Schonberg Disease (see Osteopetrosis, Malignant Recessive) Albinism, Ocular (includes Autosomal Recessive Type) Albinism, Oculocutaneous, Brown Type (Type IV) Albinism, Oculocutaneous, Tyrosinase Negative (Type IA) Albinism, Oculocutaneous, Tyrosinase Positive (Type II) Albinism, Oculocutaneous, Yellow Mutant (Type IB) Albinism-Black Locks-Deafness Albright Hereditary Osteodystrophy (see Parathyroid Hormone Resistance) Alexander Disease Alopecia - Mental Retardation Alpers Disease Alpha 1,4 - Glucosidase Deficiency (see Glycogenosis, Type IIA) Alpha-L-Fucosidase Deficiency (see Fucosidosis) Alport Syndrome (see Nephritis-Deafness, Hereditary Type) Amaurosis (see Blindness) Amaurosis
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0210567 A1 Bevec (43) Pub
    US 2010O2.10567A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0210567 A1 Bevec (43) Pub. Date: Aug. 19, 2010 (54) USE OF ATUFTSINASATHERAPEUTIC Publication Classification AGENT (51) Int. Cl. A638/07 (2006.01) (76) Inventor: Dorian Bevec, Germering (DE) C07K 5/103 (2006.01) A6IP35/00 (2006.01) Correspondence Address: A6IPL/I6 (2006.01) WINSTEAD PC A6IP3L/20 (2006.01) i. 2O1 US (52) U.S. Cl. ........................................... 514/18: 530/330 9 (US) (57) ABSTRACT (21) Appl. No.: 12/677,311 The present invention is directed to the use of the peptide compound Thr-Lys-Pro-Arg-OH as a therapeutic agent for (22) PCT Filed: Sep. 9, 2008 the prophylaxis and/or treatment of cancer, autoimmune dis eases, fibrotic diseases, inflammatory diseases, neurodegen (86). PCT No.: PCT/EP2008/007470 erative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the S371 (c)(1), present invention relates to pharmaceutical compositions (2), (4) Date: Mar. 10, 2010 preferably inform of a lyophilisate or liquid buffersolution or artificial mother milk formulation or mother milk substitute (30) Foreign Application Priority Data containing the peptide Thr-Lys-Pro-Arg-OH optionally together with at least one pharmaceutically acceptable car Sep. 11, 2007 (EP) .................................. O7017754.8 rier, cryoprotectant, lyoprotectant, excipient and/or diluent. US 2010/0210567 A1 Aug. 19, 2010 USE OF ATUFTSNASATHERAPEUTIC ment of Hepatitis BVirus infection, diseases caused by Hepa AGENT titis B Virus infection, acute hepatitis, chronic hepatitis, full minant liver failure, liver cirrhosis, cancer associated with Hepatitis B Virus infection. 0001. The present invention is directed to the use of the Cancer, Tumors, Proliferative Diseases, Malignancies and peptide compound Thr-Lys-Pro-Arg-OH (Tuftsin) as a thera their Metastases peutic agent for the prophylaxis and/or treatment of cancer, 0008.
    [Show full text]